Treatment of cancer patients in their last month of life: aimless chemotherapy

详细信息    查看全文

• 作者：Tarek Assi ; Elie El Rassy ; Samer Tabchi ; Toni Ibrahim…
• 关键词：Middle Eastern ; CLML ; End of life ; Cancer ; Chemotherapy ; Palliative care
• 刊名：Supportive Care in Cancer
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：24
• 期：4
• 页码：1603-1608
• 全文大小：264 KB
• 参考文献：1.Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol Off J Am Soc Clin Oncol 22(2):315–321CrossRef
  2.Braga S (2011) Why do our patients get chemotherapy until the end of life? Ann Oncol Off J Eur Soc Med Oncol 22(11):2345–2348CrossRef
  3.Tanneberger S, Malavasi I, Mariano P, Pannuti F, Strocchi E (2002) Planning palliative or terminal care: the dilemma of doctors’ prognoses in terminally ill cancer patients. Ann Oncol Off J Eur Soc Med Oncol 13(8):1320–1322, author reply 1322–3 CrossRef
  4.Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM et al (2012) American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol Off J Am Soc Clin Oncol 30(14):1715–1724CrossRef
  5.O’Brien MER, Borthwick A, Rigg A, Leary A, Assersohn L, Last K et al (2006) Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients. Br J Cancer 95(12):1632–1636PubMedCentral CrossRef PubMed
  6.van Eechoud IJ, Piers RD, Van Camp S, Grypdonck M, Van Den Noortgate NJ, Deveugele M et al (2014) Perspectives of family members on planning end-of-life care for terminally ill and frail older people. J Pain Symptom Manag 47(5):876–886CrossRef
  7.Jaul E, Zabari Y, Brodsky J (2014) Spiritual background and its association with the medical decision of, DNR at terminal life stages. Arch Gerontol Geriatr 58(1):25–29CrossRef PubMed
  8.Mack JW, Walling A, Dy S, Antonio ALM, Adams J, Keating NL et al (2015) Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer. Cancer 121(11):1891–1897CrossRef PubMed
  9.Ajrouch KJ, Abdulrahim S, Antonucci TC (2015) Family relations and health over the life course. A Lebanese perspective. J Méd Liban 63(1):8–14PubMed
  10.Naifeh Khoury M (2008) Palliative care education in Lebanon: past endeavors and future outlook. J Méd Liban 56(2):83–85PubMed
  11.Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer Oxf Engl 1990;45(2):228–47
  12.Lee HS, Chun KH, Moon D, yeon HK, Lee S, Lee S (2015) Trends in receiving chemotherapy for advanced cancer patients at the end of life. BMC Palliat Care [Internet]. [cited 2015 Aug 11];14. Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pmc/​articles/​PMC4365766/​
  13.Doumit MAA, Abu-Saad Huijer H, Kelley JH (2007) The lived experience of Lebanese oncology patients receiving palliative care. Eur J Oncol Nurs 11(4):309–319CrossRef PubMed
  14.Hamadeh GN, Adib SM (1998) Cancer truth disclosure by Lebanese doctors. Soc Sci Med 47(9):1289–1294CrossRef PubMed
  15.Sanz Ortiz J (2012) Chemotherapy at the end of life: up until when? Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 14(9):667–674
  16.Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC (2011) Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol Off J Am Soc Clin Oncol 29(12):1587–1591CrossRef
  17.Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–1625PubMedCentral CrossRef PubMed
  18.Ahn DH, Bekaii-Saab T (2014) Ampullary cancer: an overview. Am Soc Clin Oncol Educ Book ASCO Am Soc Clin Oncol Meet. 112–5
  19.Mayrbäurl B, Giesinger JM, Burgstaller S, Piringer G, Holzner B, Thaler J (2015) Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study. Support Care Cancer Off J Multinatl Assoc Support Care Cancer
  20.Gilliam LAA, St Clair DK (2011) Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal 15(9):2543–2563PubMedCentral CrossRef PubMed
  21.Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 15(1):110–115
  22.Gandara DR, Gumerlock PH (2005) Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out? J Clin Oncol 23(25):5856–5858CrossRef PubMed
  23.Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS et al (2012) Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol 30(4):394–400CrossRef
  24.Sezgin Goksu S, Gunduz S, Unal D, Uysal M, Arslan D, Tatlı AM et al (2014) Use of chemotherapy at the end of life in Turkey. BMC Palliat Care 13(1):51PubMedCentral CrossRef PubMed
  25.Kao S, Shafiq J, Vardy J, Adams D (2009) Use of chemotherapy at end of life in oncology patients. Ann Oncol Off J Eur Soc Med Oncol 20(9):1555–1559CrossRef
  26.Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ. et al. (2015) Chemotherapy Use, Performance Status, and Quality of Life at the End of Life. JAMA Oncol
  27.Mohammed AA, Al-Zahrani AS, Ghanem HM, Farooq MU, El Saify AM, El-Khatib HM (2015) End-of-life palliative chemotherapy: where do we stand? J Egypt Natl Cancer Inst 27(1):35–39CrossRef
  28.Martoni AA, Tanneberger S, Mutri V (2007) Cancer chemotherapy near the end of life: the time has come to set guidelines for its appropriate use. Tumori 93(5):417–422PubMed
  29.Keam B, Oh D-Y, Lee S-H, Kim D-W, Kim MR, Im S-A et al (2008) Aggressiveness of cancer-care near the end-of-life in Korea. Jpn J Clin Oncol 38(5):381–386CrossRef PubMed
  
• 作者单位：Tarek Assi (1)
  Elie El Rassy (1)
  Samer Tabchi (1)
  Toni Ibrahim (1)
  Tania Moussa (2)
  Ralph Chebib (1)
  Fadi El Karak (1)
  Fadi Farhat (1)
  Georges Chahine (1)
  Fadi Nasr (1)
  Marwan Ghosn (1)
  Joseph Kattan (1)
  
  1. Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
  2. Department of Radiology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Nursing
  Nursing Management and Research
  Pain Medicine
  Rehabilitation Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-7339

文摘

Purpose The use of chemotherapy in the last month of life (CLML) of cancer patients is considered an aggressive approach to be avoided. We examined the practice of CLML in Lebanese cancer patients, and we investigated patient and tumor characteristics that justify this practice. To our knowledge, this is the first study describing CLML of Middle Eastern patients with advanced cancer.